- Home
- CRC vs RNA Comparison
CRC vs RNA Comparison
Compare CRC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRC
- RNA
- Stock Information
- Founded
- CRC 2014
- RNA 2012
- Country
- CRC United States
- RNA United States
- Employees
- CRC N/A
- RNA N/A
- Industry
- CRC Oil & Gas Production
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- CRC Energy
- RNA Health Care
- Exchange
- CRC Nasdaq
- RNA Nasdaq
- Market Cap
- CRC 4.2B
- RNA 4.0B
- IPO Year
- CRC N/A
- RNA 2020
- Fundamental
- Price
- CRC $49.89
- RNA $46.35
- Analyst Decision
- CRC Strong Buy
- RNA Strong Buy
- Analyst Count
- CRC 12
- RNA 15
- Target Price
- CRC $63.00
- RNA $68.40
- AVG Volume (30 Days)
- CRC 875.3K
- RNA 3.7M
- Earning Date
- CRC 08-05-2025
- RNA 08-07-2025
- Dividend Yield
- CRC 3.22%
- RNA N/A
- EPS Growth
- CRC 205.84
- RNA N/A
- EPS
- CRC 7.21
- RNA N/A
- Revenue
- CRC $3,624,000,000.00
- RNA $10,729,000.00
- Revenue This Year
- CRC $20.98
- RNA N/A
- Revenue Next Year
- CRC N/A
- RNA $110.16
- P/E Ratio
- CRC $6.92
- RNA N/A
- Revenue Growth
- CRC 60.00
- RNA 1.23
- 52 Week Low
- CRC $30.97
- RNA $21.51
- 52 Week High
- CRC $60.41
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- CRC 59.03
- RNA 68.29
- Support Level
- CRC $47.05
- RNA $43.28
- Resistance Level
- CRC $48.53
- RNA $47.50
- Average True Range (ATR)
- CRC 1.53
- RNA 2.72
- MACD
- CRC 0.01
- RNA -0.23
- Stochastic Oscillator
- CRC 59.10
- RNA 85.32
About CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.